Federated Hermes’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.5M | Sell |
|
|||||
|
2025
Q1 | $74.4M | Buy |
|
|||||
|
2024
Q4 | $86.2M | Sell |
|
|||||
|
2024
Q3 | $117M | Buy |
|
|||||
|
2024
Q2 | $86.6M | Buy |
|
|||||
|
2024
Q1 | $90.5M | Sell |
|
|||||
|
2023
Q4 | $117M | Buy |
|
|||||
|
2023
Q3 | $78.3M | Buy |
|
|||||
|
2023
Q2 | $82M | Sell |
|
|||||
|
2023
Q1 | $101M | Sell |
|
|||||
|
2022
Q4 | $143M | Sell |
|
|||||
|
2022
Q3 | $158M | Buy |
|
|||||
|
2022
Q2 | $227M | Sell |
|
|||||
|
2022
Q1 | $290M | Buy |
|
|||||
|
2021
Q4 | $335M | Sell |
|
|||||
|
2021
Q3 | $360M | Buy |
|
|||||
|
2021
Q2 | $367M | Sell |
|
|||||
|
2021
Q1 | $445M | Sell |
|
|||||
|
2020
Q4 | $593M | Buy |
|
|||||
|
2020
Q3 | $337M | Buy |
|
|||||
|
2020
Q2 | $319M | Buy |
|
|||||
|
2020
Q1 | $178M | Buy |
|
|||||
|
2019
Q4 | $127M | Buy |
|
|||||
|
2019
Q3 | $122M | Buy |
|
|||||
|
2019
Q2 | $113M | Buy |
|
|||||
|
2019
Q1 | $121M | Buy |
|
|||||
|
2018
Q4 | $55.5M | Sell |
|
|||||
|
2018
Q3 | $113M | Buy |
|
|||||
|
2018
Q2 | $109M | Buy |
|
|||||
|
2018
Q1 | $61.2M | Buy |
|
|||||
|
2017
Q4 | $51.1M | Buy |
|
|||||
|
2017
Q3 | $20.9M | Sell |
|
|||||
|
2017
Q2 | $25.9M | Hold |
|
|||||
|
2017
Q1 | $28.3M | Sell |
|
|||||
|
2016
Q4 | $30.8M | Sell |
|
|||||
|
2016
Q3 | $31.4M | Sell |
|
|||||
|
2016
Q2 | $21.7M | Hold |
|
|||||
|
2016
Q1 | $28M | Buy |
|
|||||
|
2015
Q4 | $44.9M | Buy |
|
|||||
|
2015
Q3 | $38.4M | Buy |
|
|||||
|
2015
Q2 | $40.8M | Hold |
|
|||||
|
2015
Q1 | $24.7M | Buy |
|
|||||
|
2014
Q4 | $12.7M | Hold |
|
|||||
|
2014
Q3 | $16.4M | Buy |
|
|||||
|
2014
Q2 | $6.24M | Sell |
|
|||||
|
2014
Q1 | $6.91M | Buy |
|